Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

ClinicalTrials.gov ID: NCT06425159

Public ClinicalTrials.gov record NCT06425159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 7:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 as Adjunctive Therapy in Subjects With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures, With Open-label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of idiopathic generalized epilepsy with generalized tonic-clonic seizures and includes an additional open-label extension (OLE) phase.

Study identification

NCT ID
NCT06425159
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Biohaven Therapeutics Ltd.
Industry
Enrollment
27 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2024 (Actual)
Primary completion
Mar 12, 2026 (Actual)
Completion
Mar 12, 2026 (Actual)
Last update posted
Mar 24, 2026

2024 – 2026

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
Accel Research Birmingham Alabama 35244 —
Barrow Neurological Institute Phoenix Arizona 85013 —
ARENSIA Exploratory Medicine Phoenix Arizona 85015 —
Center for Neurosciences Tucson Arizona 85718 —
Profound Research LLC Pasadena California 91105 —
Medstar Health Research Institute Washington D.C. District of Columbia 20010 —
Nova Clinical Research, LLC Bradenton Florida 34209 —
University of Florida (Jacksonville) Jacksonville Florida 32209 —
Y&L Advance Health Care,Inc d/b/a Elite Clinical Research Miami Florida 33144 —
Serenity Research Center Miami Florida 33176 —
Research Institute of Orlando Orlando Florida 32806 —
Comprehensive Neurology Clinic Orlando Florida 32825 —
Knight Neurology Rockledge Florida 32955 —
Santos Research Center Tampa Florida 33615 —
Encore Medical Research of Weston LLC. Weston Florida 33331 —
Augusta University Augusta Georgia 30912 —
Hawaii Pacific Neuroscience Honolulu Hawaii 96817 —
Consultants in Epilepsy & Neurology, PLLC (CEN) Boise Idaho 83702 —
Northwestern Medical Group, Department of Neurology Chicago Illinois 60611 —
Revive Research Institute, Inc. Elgin Illinois 60123 —
Bluegrass Epilepsy Research Lexington Kentucky 40504 —
OLOLRMC Baton Rouge Louisiana 70808 —
University Medical Center New Orleans New Orleans Louisiana 70112 —
Boston Clinical Trials Boston Massachusetts 02131 —
Somnos Clinical Research Lincoln Nebraska 68510 —
NEREG Hackensack New Jersey 07601 —
Institute of Neurology and Neurosurgery Livingston New Jersey 07039 —
Dent Neurosciences Research Center Amherst New York 14226 —
Boston Children's Health Physicians (BCHP) Hawthorne New York 10532-1528 —
Northwell Health Pediatric Neurology New Hyde Park New York 11042 —
NYU Langone Health New York New York 10016 —
Montefiore Medical Center The Bronx New York 10467 —
UPMC Pittsburgh Pennsylvania 15213 —
WR-ClinSearch Chattanooga Tennessee 37421 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Neurology Consultants of Dallas, PA Dallas Texas 75243 —
ANESC Research El Paso Texas 79912 —
Road Runner Research, Ltd San Antonio Texas 78249 —
Intermountain Health Murray Utah 84107 —
Henrico Doctors' Neurology Associates, LLC Richmond Virginia 23235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06425159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06425159 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →